Outcomes and patterns of use of Radium-223 in metastatic castration-resistant prostate cancerJul 14, 2025 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-Estevez
Recommendations from the Galician Oncological Society and the Galician Society of Nuclear Medicine for the use of 177Lu-PSMA-617 radioligand-therapy in prostate cancerSep 12, 2024 | Francisco Javier Casas Nebra, Publicaciones científicas, Sergio Vazquez-Estevez
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate CancerJul 14, 2024 | Publicaciones científicas, Sergio Vazquez-Estevez
BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLCJun 26, 2024 | Publicaciones científicas, Sergio Vazquez-Estevez
Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trialJun 26, 2024 | Publicaciones científicas, Sergio Vazquez-Estevez
Efficacy and safety of atezolizumab concurrent with radiotherapy in patients with muscle-invasive bladder cancer: An interim of the atezobladderpreserve phase II trial (SOGUG-2017-A-IEC(VEJ)-4).May 29, 2024 | ASCO, Comunicaciones a congresos, Pilar Canoa Román, Sergio Vazquez-Estevez
SAPPHIRE Investigators. SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancerOct 20, 2023 | Publicaciones científicas, Sergio Vazquez-Estevez
